PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Silk Road Medical, Inc (SILK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS82710M1009
CUSIP82710M100
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$717.68M
EPS-$1.44
PE Ratio9.81
PEG Ratio-1.49
Revenue (TTM)$177.13M
Gross Profit (TTM)$100.76M
EBITDA (TTM)-$56.58M
Year Range$6.08 - $46.57
Target Price$20.17
Short %9.68%
Short Ratio3.71

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Silk Road Medical, Inc

Popular comparisons: SILK vs. SLV

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Silk Road Medical, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%NovemberDecember2024FebruaryMarchApril
138.56%
16.40%
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

S&P 500

Returns By Period

Silk Road Medical, Inc had a return of 42.30% year-to-date (YTD) and -60.50% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date42.30%5.29%
1 month2.77%-2.47%
6 months138.52%16.40%
1 year-60.50%20.88%
5 years (annualized)-12.50%11.60%
10 years (annualized)N/A10.43%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202423.31%18.90%1.83%
2023-22.41%-49.90%24.23%31.51%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SILK is 19, indicating that it is in the bottom 19% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of SILK is 1919
Silk Road Medical, Inc(SILK)
The Sharpe Ratio Rank of SILK is 1515Sharpe Ratio Rank
The Sortino Ratio Rank of SILK is 2222Sortino Ratio Rank
The Omega Ratio Rank of SILK is 1717Omega Ratio Rank
The Calmar Ratio Rank of SILK is 1313Calmar Ratio Rank
The Martin Ratio Rank of SILK is 3030Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Silk Road Medical, Inc (SILK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


SILK
Sharpe ratio
The chart of Sharpe ratio for SILK, currently valued at -0.73, compared to the broader market-2.00-1.000.001.002.003.00-0.73
Sortino ratio
The chart of Sortino ratio for SILK, currently valued at -0.73, compared to the broader market-4.00-2.000.002.004.00-0.73
Omega ratio
The chart of Omega ratio for SILK, currently valued at 0.88, compared to the broader market0.501.001.500.88
Calmar ratio
The chart of Calmar ratio for SILK, currently valued at -0.66, compared to the broader market0.001.002.003.004.005.00-0.66
Martin ratio
The chart of Martin ratio for SILK, currently valued at -0.98, compared to the broader market0.0010.0020.00-0.98
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.79, compared to the broader market-2.00-1.000.001.002.003.001.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.002.61
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.007.21

Sharpe Ratio

The current Silk Road Medical, Inc Sharpe ratio is -0.73. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.73
1.79
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Silk Road Medical, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-75.04%
-4.42%
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Silk Road Medical, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Silk Road Medical, Inc was 91.01%, occurring on Oct 25, 2023. The portfolio has not yet recovered.

The current Silk Road Medical, Inc drawdown is 75.04%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.01%Nov 9, 2020745Oct 25, 2023
-52.85%Jun 20, 2019188Mar 18, 202097Aug 5, 2020285
-13.65%Sep 21, 202026Oct 26, 20208Nov 5, 202034
-12.49%May 23, 20197Jun 3, 20195Jun 10, 201912
-12.26%Apr 11, 20195Apr 17, 20195Apr 25, 201910

Volatility

Volatility Chart

The current Silk Road Medical, Inc volatility is 15.38%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%NovemberDecember2024FebruaryMarchApril
15.38%
3.35%
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Silk Road Medical, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items